Solon, IA, United States of America

Fred S Lamb


Average Co-Inventor Count = 1.5

ph-index = 1


Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fred S. Lamb: Innovator in Vascular Modulation

Introduction

Fred S. Lamb is a notable inventor based in Solon, Iowa, who has made significant contributions to the field of vascular health. With a focus on chloride channel blockers, his work aims to improve the treatment of patients with compromised vascular tissue. He holds 2 patents that reflect his innovative approach to medical challenges.

Latest Patents

Fred S. Lamb's latest patents include groundbreaking methods for modulating vascular tone. One patent details the use of ClC3 chloride channel blockers to enhance vascular function in patients with compromised vascular tissue. This invention provides methods that involve administering a chloride channel blocking agent or a pharmaceutically acceptable salt thereof. Another patent focuses on reducing the sensitivity of endothelially-compromised vascular smooth muscle. This invention outlines materials and methods that utilize CLC3 blockers, particularly compounds of a specific formula, to treat sensitivity in affected patients.

Career Highlights

Fred S. Lamb is affiliated with the University of Iowa Research Foundation, where he conducts research and develops innovative solutions for vascular health issues. His work is characterized by a commitment to improving patient outcomes through scientific advancements.

Collaborations

Fred has collaborated with esteemed colleagues such as Brian C. Schutte and Baoli Yang, contributing to a rich environment of innovation and research.

Conclusion

Fred S. Lamb's contributions to the field of vascular modulation through his patents and research at the University of Iowa Research Foundation highlight his dedication to advancing medical science. His work continues to pave the way for improved treatments in vascular health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…